Emily King worked as a research associate in the Sabeti Lab from 2019 – 2021. Her worked focused on engineering tissue-targeted AAVs for in vivo gene delivery and therapeutic applications. Emily is now pursuing a PhD in the Biological and Biomedical Sciences at Harvard University where she hopes to continue contributing to novel therapeutic research and development.